Dr. Diana Zuckerman, President of the NCHR: September 17, 2018.
In the largest study ever conducted of long-term health risks for patients with breast implants, researchers at The University of Texas MD Anderson Cancer Center have reported that women with silicone implants are more likely to be diagnosed with several rare diseases, autoimmune disorders, and other conditions. These results are consistent with numerous previously published studies, but contradict the conclusions of studies funded by implant manufacturers or plastic surgery medical societies.
The study, published in the September issue of the medical journal Annals of Surgery, is by researchers in MD Anderson’s Department of Plastic Surgery and is based on analyses of almost 100,000 patients with either saline or silicone implants. The information was derived from the FDA’s database dating back to 2005. When the FDA approved silicone gel breast implants made by two manufacturers in 2006, the agency required that each of the manufacturers study at least 40,000 women for 10 years. Those studies were started but never completed, making it impossible to determine the long-term risks of breast implants. In the absence of such crucial studies, patients report that they were not warned about the risks when they decided to get breast implants.
We thank Mark W. Clemens, M.D., associate professor, Plastic Surgery, the senior investigator of this very important study. The findings are consistent with what thousands of women with breast implants have reported in Facebook groups and other social media, and directly challenge the FDA’s claims that breast implants do not cause such diseases. We urge the FDA to be more patient-centered and finally require independent studies be conducted of women before and after their breast implants are removed. Many women have reported that their debilitating autoimmune symptoms decreased or disappeared after their breast implants were removed, but scientific data is needed to establish the rate of recovery.